This is a routine director 144 filing with negligible market impact. The small share count and derivative-based acquisition suggest compensation-related liquidity, not information-motivated selling. No actionable trade signal.
Price Chart
Executive Summary
Director Daniella Beckman filed a Form 144 notice of intent to sell 4,446 shares of Tango Therapeutics common stock, with an approximate market value of $133,380 based on a $30.00 reference price. The shares being sold amount to less than 0.01% of the company's $4.6B market cap and represent stock acquired through option exercise and restricted stock vesting. This is a routine and immaterial insider sale by a director, consistent with compensation-related share liquidation.
Key Facts
- Director Daniella Beckman filed Form 144 to sell 4,446 shares of Tango Therapeutics
- Approximate market value of proposed sale: $133,380
- Shares acquired via stock option exercise (914 shares) and restricted stock vesting (3,532 shares from 2017 grants)
- Sale represents ~0.003% of $4.6B market cap — immaterial dilution concern
- Filing is a notice of intent to sell under Rule 144, not a completed transaction
Financial Impact
Proposed sale of 4,446 shares worth approximately $133,380, less than 0.01% of market cap
Risk Factors
- Form 144 signals intent to sell but does not guarantee the sale will execute
- Insider could be diversifying holdings, though amount is trivial relative to total position
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005901 |
| Document: 0001950047-26-005901-index.html | 0001950047-26-005901 |
| Document: 0001950047-26-005901.txt | 0001950047-26-005901 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | 8-K | $25.58 $25.20 | ▲ +1.49% | ▲ +1.04% | $23.20 (+9.28%) |
Aug 11, 2026 7w ago | 8-K | $26.34 $25.44 | ▼ −3.42% | ▼ −3.01% | $23.20 (−11.90%) |
Aug 11, 2026 7w ago | Press Release | $26.34 $25.44 | ▼ −3.42% | ▼ −3.01% | $23.20 (−11.90%) |
Aug 9, 2026 7w ago | Institutional Cluster | $27.67 $25.29 | ▼ −8.60% | ▼ −8.55% | $23.20 (−16.14%) |
Aug 6, 2026 8w ago | 8-K | $27.07 $25.60 | ▼ −5.43% | ▼ −5.83% | $23.20 (−14.28%) |
Jun 11, 2026 16w ago | 144 | $30.94 $27.97 | ▼ −9.60% | ▼ −10.27% | $23.20 (−25.00%) |
Jun 11, 2026 16w ago | Institutional Cluster | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 11, 2026 16w ago | Institutional Cluster | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 10, 2026 16w ago | 424B5 | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 10, 2026 16w ago | 144 | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access